Table 4 Antimicrobial intermediary and antimicrobial susceptibilities of 56 patients
Drug | Susceptible % | Intermediate % | Resistant % | MIC50 | MIC90 | Breakpoint |
|---|---|---|---|---|---|---|
Vancomycin | 100 (49/49) | 0.00 (49/49) | 0.00 (49/49) | 0.5 | 0.5 | S ≤ 2 |
Linezolid | 100 (38/38) | 0.00 (38/38) | 0.00 (38/38) | 0.25 | 0.5 | S ≤ 2 |
Rifampin | 100 (27/27) | 0.00 (27/27) | 0.00 (27/27) | 0.008 | 0.008 | S ≤ 1, R ≥ 4 |
Meropenem | 87.50 (42/48) | 4.17 (2/48) | 8.33 (4/48) | 0.064 | 0.5 | S ≤ 0.25, R ≥ 1 |
Gentamicin | 94.12 (32/34) | 0.00 (0/34) | 5.88 (2/34) | 0.125 | 0.5 | S ≤ 4, R ≥ 16 |
Trimethoprim -sulfamethoxazole | 77.36 (41/53) | 0.00 (0/53) | 22.64 (12/53) | 0.25 | 32 | S ≤ 2/38, R ≥ 4/76 |
Ciprofloxacin | 69.09 (38/55) | 0.00 (0/55) | 30.91 (17/55) | 0.25 | 32 | S ≤ 1, R ≥ 4 |
Ceftriaxone | 50.00 (28/56) | 14.29 (8/56) | 35.71 (20/56) | 1 | 8 | S ≤ 1, R ≥ 4 |
Tetracycline | 41.46 (17/41) | 48.78 (20/41) | 9.76 (4/41) | 8 | 8 | S ≤ 4, R ≥ 16 |
Clindamycin | 23.26 (10/43) | 0.00 (0/43) | 76.74 (33/43) | 256 | 256 | S ≤ 0.5, R ≥ 4 |
Erythromycin | 19.64 (11/56) | 1.79 (1/56) | 78.57 (44/56) | 16 | 256 | S ≤ 0.5, R ≥ 2 |
Penicillin | 0.00 (0/56) | 89.29 (50/56) | 10.71 (6/56) | 0.5 | 2 | S ≤ 0.12, R ≥ 4 |